RVW Wealth’s Turn Therapeutics TTRX Stock Holding History

RVW Wealth’s Portfolio TTRX Stock Details TTRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-18,000	Closed	-$131K	–	190
2026 Q2	$131K	Hold	18,000	–	–	0.01%	182
2026 Q1	$57.6K	Hold	18,000	–	–	﹤0.01%	175
2025 Q4	$70.9K	Buy	+18,000	New	+$75K	0.01%	179

Other funds holding TTRX

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

McCarthy Asset Management Redwood Shores, California $209M AUM

Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

RVW Wealth's TTRX Position: Q3 2026 in Review

RVW Wealth sold out of Turn Therapeutics (TTRX) in Q3 2026, closing a stake of 18,000 shares — an estimated $131K sold.

RVW Wealth first reported a position in TTRX in Q4 2025 and held it in 3 quarters. The position peaked at $131K in Q2 2026. 7 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

RVW Wealth reported no remaining Turn Therapeutics position as of Q3 2026 after selling out during the quarter.
RVW Wealth sold 18,000 Turn Therapeutics shares in Q3 2026, an estimated $131K.
RVW Wealth first reported a position in Turn Therapeutics in Q4 2025 and held it in 3 quarters.
RVW Wealth's Turn Therapeutics position peaked at $131K in Q2 2026.
7 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on RVW Wealth's 13F filing for Q3 2026, filed 6 Oct 2026.